Under pan-cancer analysis, we successfully identified that MPZL3 acts as a pan-cancer gene and investigated its differential expression, prognostic value, tumor immune infiltration, and drug susceptibility in human cancers. This evidence concerns the gene MPZL3 and neoplasm.